Development of a bioreactor-system for pre-endothelialized cardiac patch generation with enhanced viscoelastic properties by combined collagen I compression and stromal cell culture
- Treatment of terminal heart failure still poses a significant clinical problem. Cardiac tissue engineering could offer autologous solutions for the replacement of non-functional myocardial tissue. So far, soft matrix construction and missing large scale prevascularization prevented the application of sizeable cardiac repair patches. We developed a novel bioreactor system for semi-automatic compression of a collagen I hydrogel applying 16 times higher pressure than in previous studies.
- Resistance towards compression stress was investigated for multiple cardiac-related cell types. For scaffold prevascuarization, a tubular cavity was imprinted during the compaction process. Primary cardiac-derived endothelial cells (EC) were isolated from human left atrial appendages (HLAA) and characterized by FACS and immunocytology. EC were then seeded into the preformed channel with dermal fibroblasts as interstitial cell component of the fully cellularized patch.
- After eight days of constant perfusion culture within the same bioreactor, scaffold dynamic modulus and cell viability were analyzed. Endothelial proliferation and vessel maturation were examined by immunohistochemistry and transmission electron microscopy. Our design allowed for scaffold production and dynamic culture in a one-stop-shop model.
- Enhanced compression and cell-mediated matrix remodeling induced a significant increase in scaffold stiffness while ensuring excellent cell survival. For the first time, we could isolate HLAA-derived EC with proliferative potential.
- Endothelial cells within the central channel proliferated during flow culture, continuously expressing endothelial markers (CD31) and displaying basal membrane synthesis (collagen IV, ultrastructural analysis). After seven days of culture, a complete endothelial monolayer could be observed. Covering cells aligned themselves in flow direction and developed mature cell-cell-contacts.
pharmacodane
IGF-1, human |
|||
RC216-12 | Bio Basic | 1mg | EUR 451.5 |
IGF-1 Protein |
|||
abx060289-100ug | Abbexa | 100 ug | EUR 493.2 |
IGF-1 Antibody |
|||
E19-6096 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
IGF-1 Antibody |
|||
E90303 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
IGF-1 Antibody |
|||
R30443 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Insulin-like growth factor 1, also known as somatomedin C or mechano growth factor is a protein that in humans is encoded by the IGF1 gene. IGF-1 is a hormone similar in molecular structure to insulin. It plays an important role in childhood growth and continues to have anabolic effects in adults. A synthetic analog of the protein, mecasermin, is used for the treatment of growth failure. IGF-1 consists of 70 amino acids in a single chain with three intramolecular disulfide bridges. |
IGF- 1 Plasmid |
|||
PVT7112 | Lifescience Market | 2 ug | EUR 319.2 |
IGF- 1 Antibody |
|||
ABD6096 | Lifescience Market | 100 ug | EUR 525.6 |
RM-1 Cell Line |
|||
CL-0198 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 420 |
Description: Mus musculus, Mouse |
rHu IGF-1 (cGMP) |
|||
AK9901-0000 | Akron Biotech | 1mg | Ask for price |
IGF-1 ELISA Kit |
|||
DEIA1901 | Creative Diagnostics | 96T | EUR 908.4 |
Description: The IGF-1 ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of Insulin-like Growth Factor 1 (IGF-1) in serum. |
Human IGF-1 LR3 |
|||
SP-89927-100 | Alpha Diagnostics | 100 ug | EUR 270 |
IGF-1 ELISA Kit |
|||
80572 | Crystal Chem | 96 | EUR 490 |
Human IGF-1 ELISA |
|||
TBS3251 | Tribioscience | 1x96-well plate | EUR 450 |
Description: Cell culture Supernate, Plasma/Serum IGF-1 |
IGF-1(M23) Antibody |
|||
BNCH0220-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(M23), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNCH0220-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(M23), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC700220-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(M23), CF770 conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC700220-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(M23), CF770 conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC800220-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(M23), CF680 conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC800220-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(M23), CF680 conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC810220-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(M23), CF680R conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC810220-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(M23), CF680R conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC550220-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(M23), CF555 conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC550220-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(M23), CF555 conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC430220-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(M23), CF543 conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC430220-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(M23), CF543 conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC610220-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(M23), CF660R conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC610220-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(M23), CF660R conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC050220-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(M23), CF405M conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNC050220-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(M23), CF405M conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNCA0220-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against IGF-1(M23), APC conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNCAP0220-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(M23), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNCAP0220-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(M23), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNCP0220-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against IGF-1(M23), PerCP conjugate, Concentration: 0.1mg/mL |
IGF-1(M23) Antibody |
|||
BNCR0220-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against IGF-1(M23), RPE conjugate, Concentration: 0.1mg/mL |
Mouse IGF-1 Antibody |
|||
33079-05111 | AssayPro | 150 ug | EUR 215 |
Recombinant Rat IGF-1 |
|||
REGFP-0901 | Cyagen | 10ug | Ask for price |
IGF-1 Blocking Peptide |
|||
DF6096-BP | Affbiotech | 1mg | EUR 234 |
Recombinant Human IGF-1 |
|||
HEGFP-0901 | Cyagen | 100ug | Ask for price |
IGF-1, human recombinant |
|||
P1016-.02 | ApexBio | 20 µg | EUR 309.6 |
Description: Insulin-like growth factor I (IGF-1) is a polypeptide endocrine hormone structurally similar to insulin and is mainly produced in the liver when stimulated by growth hormone. IGF-1 is a growth factor that stimulates the proliferation of various cell types including muscle, bone, and cartilage tissue |
IGF-1, human recombinant |
|||
P1016-.1 | ApexBio | 100 µg | EUR 598 |
Description: IGF-1, endocrine hormone, expressed in E.Coli, cross-species reactivity. |
Recombinant Murine IGF-1 |
|||
MEGFP-0614 | Cyagen | 10ug | Ask for price |
RM 06 |
|||
T26101-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: RM 06 |
RM 06 |
|||
T26101-1g | TargetMol Chemicals | 1g | Ask for price |
Description: RM 06 |
RM 06 |
|||
T26101-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: RM 06 |
RM 06 |
|||
T26101-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: RM 06 |
RM 06 |
|||
T26101-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: RM 06 |
RM 49 |
|||
T26102-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: RM 49 |
RM 49 |
|||
T26102-1g | TargetMol Chemicals | 1g | Ask for price |
Description: RM 49 |
RM 49 |
|||
T26102-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: RM 49 |
RM 49 |
|||
T26102-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: RM 49 |
RM 49 |
|||
T26102-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: RM 49 |
RM-133 |
|||
T34335-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: RM-133 |
RM-133 |
|||
T34335-1g | TargetMol Chemicals | 1g | Ask for price |
Description: RM-133 |
RM-133 |
|||
T34335-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: RM-133 |
RM-133 |
|||
T34335-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: RM-133 |
RM-133 |
|||
T34335-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: RM-133 |
RM-018 |
|||
T40269-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: RM-018 |
RM-018 |
|||
T40269-1g | TargetMol Chemicals | 1g | Ask for price |
Description: RM-018 |
RM-018 |
|||
T40269-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: RM-018 |
RM-018 |
|||
T40269-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: RM-018 |
RM-018 |
|||
T40269-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: RM-018 |
IGF-1(IGF1/1020) Antibody |
|||
BNCH1020-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(IGF1/1020), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNCH1020-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(IGF1/1020), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNCAP1020-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(IGF1/1020), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNCAP1020-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(IGF1/1020), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC701020-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF770 conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC701020-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF770 conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC811020-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF680R conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC811020-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF680R conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC801020-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF680 conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC801020-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF680 conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC551020-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF555 conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC551020-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF555 conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC431020-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF543 conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC431020-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF543 conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC611020-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF660R conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC611020-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF660R conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC051020-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF405M conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNC051020-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against IGF-1(IGF1/1020), CF405M conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNCA1020-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against IGF-1(IGF1/1020), APC conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNCP1020-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against IGF-1(IGF1/1020), PerCP conjugate, Concentration: 0.1mg/mL |
IGF-1(IGF1/1020) Antibody |
|||
BNCR1020-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against IGF-1(IGF1/1020), RPE conjugate, Concentration: 0.1mg/mL |
IGF-I (1-3) |
|||
4026104.025 | Bachem | 250 mg | EUR 112.35 |
IGF-I (1-3) |
|||
4026104.1 | Bachem | 1 g | EUR 337.05 |
IGF-I (1-3) |
|||
5-01367 | CHI Scientific | 4 x 5mg | Ask for price |
IGF-I (1-3) |
|||
H-2468.0250 | Bachem | 250.0mg | EUR 211.2 |
Description: Sum Formula: C12H19N3O6; CAS# [32302-76-4] |
IGF-I (1-3) |
|||
H-2468.1000 | Bachem | 1.0g | EUR 559.2 |
Description: Sum Formula: C12H19N3O6; CAS# [32302-76-4] |
IGF-1(M23), 1mg/mL |
|||
BNUM0220-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
IGF-1(M23), 0.2mg/mL |
|||
BNUB0220-100 | Biotium | 100uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
IGF-1(M23), 0.2mg/mL |
|||
BNUB0220-500 | Biotium | 500uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Rat IGF-1 ELISA kit |
|||
LF-EK50545 | Abfrontier | 1×96T | EUR 777.6 |
Rat IGF-1 ELISA Kit |
|||
GWB-ZZD062 | GenWay Biotech | 1x96 well plate | Ask for price |
Rat IGF-1 ELISA Kit |
|||
80573 | Crystal Chem | 96 | EUR 490 |
IGF-1, DES1-3, human |
|||
RC216-12B | Bio Basic | 100ug | EUR 203.56 |
IGF-1 ELISA KIT|Human |
|||
EF000135 | Lifescience Market | 96 Tests | EUR 826.8 |
Human IGF-1 ELISA Kit |
|||
E28L0569 | EnoGene | 96T | EUR 666.67 |
Human IGF-1 ELISA KIT |
|||
E42EH-82 | EnoGene | 96T/48T | Ask for price |
Mouse IGF-1 ELISA kit |
|||
LF-EK50549 | Abfrontier | 1×96T | EUR 777.6 |
Mouse IGF-1 ELISA Kit |
|||
GWB-SKR077 | GenWay Biotech | 96 Tests | Ask for price |
Human IGF-1 ELISA Kit |
|||
GWB-SKR125 | GenWay Biotech | 96 Tests | Ask for price |
Mouse IGF-1 ELISA Kit |
|||
GWB-ZZD063 | GenWay Biotech | 1x96 well plate | Ask for price |
IGF-1 (human) ELISA Kit |
|||
K4775-100 | Biovision | 100 assays | EUR 970.8 |
Description: Sensitive, Colorimetric Assay |
Mouse IGF-1 ELISA Kit |
|||
80574 | Crystal Chem | 96 | EUR 490 |
IGF-1R |
|||
GWB-A96843 | GenWay Biotech | 0.01 mg | Ask for price |
IGF-1 (Murine) ELISA Kit |
|||
EKA51893-5x96T | Biomatik Corporation | 5x96T | Ask for price |
IGF-1 (Murine) ELISA Kit |
|||
EKA51893-96T | Biomatik Corporation | 96T | EUR 446.9 |
IGF-1, N15 labeled, human |
|||
RC216-12N | Bio Basic | 5ug | EUR 125.26 |
Antibody for Human IGF-1 |
|||
SPC-699D-A565 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 565. |
Antibody for Human IGF-1 |
|||
SPC-699D-A633 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 633. |
Antibody for Human IGF-1 |
|||
SPC-699D-A655 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 655. |
Antibody for Human IGF-1 |
|||
SPC-699D-A680 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 680. |
Antibody for Human IGF-1 |
|||
SPC-699D-A700 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to ATTO 700. |
Antibody for Human IGF-1 |
|||
SPC-699D-APCCY7 | Stressmarq | 0.1mg | EUR 565.2 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to APC/Cy7. |
Antibody for Human IGF-1 |
|||
SPC-699D-DY350 | Stressmarq | 0.1mg | EUR 496.8 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 350. |
Antibody for Human IGF-1 |
|||
SPC-699D-DY405 | Stressmarq | 0.1mg | EUR 483.6 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 405. |
Antibody for Human IGF-1 |
|||
SPC-699D-DY488 | Stressmarq | 0.1mg | EUR 471.6 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 488. |
Antibody for Human IGF-1 |
|||
SPC-699D-DY594 | Stressmarq | 0.1mg | EUR 474 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 594. |
Antibody for Human IGF-1 |
|||
SPC-699D-DY633 | Stressmarq | 0.1mg | EUR 468 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Dylight 633. |
Antibody for Human IGF-1 |
|||
SPC-699D-P594 | Stressmarq | 0.1mg | EUR 488.4 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to PE/ATTO 594. |
Antibody for Human IGF-1 |
|||
SPC-699D-STR | Stressmarq | 0.1mg | EUR 477.6 |
Description: A polyclonal antibody for IGF-1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the mid-protein of Human IGF-1. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100); IHC (1:50). This IGF-1 antibody is conjugated to Streptavidin. |
Anti-Rat IGF-1 Antibody |
|||
5121-100 | Biovision | each | EUR 379.2 |
Anti-Rat IGF-1 Antibody |
|||
5121-30T | Biovision | each | EUR 175.2 |
Human IGF-1 GENLISA ELISA |
|||
KBH0103 | Krishgen | 1 x 96 wells | EUR 286 |
R³ IGF-1, human recombinant |
|||
4216-100 | Biovision | each | EUR 196.8 |
R³ IGF-1, human recombinant |
|||
4216-1G | Biovision | each | EUR 48018 |
R³ IGF-1, human recombinant |
|||
4216-1MG | Biovision | each | EUR 385.2 |
R³ IGF-1, human recombinant |
|||
4216-20MG | Biovision | each | EUR 2461.2 |
R³ IGF-1, human recombinant |
|||
4216-50MG | Biovision | each | EUR 4164 |
R³ IGF-1, human recombinant |
|||
4216-5MG | Biovision | each | EUR 1011.6 |
Anti-Human IGF-1 Antibody |
|||
102-P28 | ReliaTech | 100 µg | EUR 245.7 |
Description: Insulin-like growth factor (IGF)-I (also known as somatomedin C and somatomedin A) and IGF-II (multiplication stimulating activity or MSA) belong to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGF-I and IGF-II share approximately 70% sequence identity. Both IGF-I and IGF-II are expressed in many tissues and cell types and may have autocrine, paracrine and endocrine functions. Mature IGF-I and IGF-II are highly conserved between the human, bovine and porcine proteins (100% identity), and exhibit cross-species activity. |
Anti-Mouse IGF-1 Antibody |
|||
103-M240 | ReliaTech | 100 µg | EUR 399 |
Description: Insulin-like growth factor (IGF)-I (also known as somatomedin C and somatomedin A) and IGF-II (multiplication stimulating activity or MSA) belong to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGF-I and IGF-II share approximately 70% sequence identity. Both IGF-I and IGF-II are expressed in many tissues and cell types and may have autocrine, paracrine and endocrine functions. Mature IGF-I and IGF-II are highly conserved between the human, bovine and porcine proteins (100% identity), and exhibit cross-species activity. |
Anti-Mouse IGF-1 Antibody |
|||
103-P08G | ReliaTech | 100 µg | EUR 245.7 |
Description: Insulin-like growth factor (IGF)-I (also known as somatomedin C and somatomedin A) and IGF-II (multiplication stimulating activity or MSA) belong to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGF-I and IGF-II share approximately 70% sequence identity. Both IGF-I and IGF-II are expressed in many tissues and cell types and may have autocrine, paracrine and endocrine functions. Mature IGF-I and IGF-II are highly conserved between the human, bovine and porcine proteins (100% identity), and exhibit cross-species activity. |
Plant cell cultures as food-aspects of sustainability and safety
Sustainability and safety aspects of plant cell cultures as food are presented. Applicability of dairy side streams as carbon source and use of natural growth enhancers in cultivation are shown. Biotechnologically produced cellular products are currently emerging to replace and add into the portfolio of agriculturally derived commodities.
Plant cell cultures used for food could supplement current food production. However, still many aspects need to be resolved before this new food concept can enter the market. Issues related to sustainability and safety for human consumption are relevant for both consumers and regulators. In this study, two plant cell cultures, deriving from arctic bramble (Rubus arcticus) and birch (Betula pendula), were cultivated using lactose-rich dairy side streams as alternative carbon sources to replace sucrose.
Biomasses were comparable to those of original plant cell culture media when up to 83% and 75% of the original sucrose was replaced by these side streams for arctic bramble and birch cell cultures, respectively. Furthermore, nutritional composition or sensory properties were not compromised. Synthetic plant growth regulators were replaced by natural components, such as coconut water and IAA for several subculture cycles.
Finally, it was shown that only trace amounts of free growth regulators are present in the cells at the harvesting point and assessment by freshwater crustaceans assay indicated that toxicity of the cells was not exceeding that of traditionally consumed bilberry fruit.
Stability of live attenuated classical swine fever cellculture vaccine virus in liquid form for developing an oral vaccine
Classical swine fever (CSF) is an important viral disease of pigs and controlled by vaccination. Unorganised backyard and wild pigs are difficult to vaccinate by needle vaccination. Here we formulated liquid vaccines using an Indian CSF cell culture vaccine virus and four stabilisers and evaluated their stability at 4 °C, 25 °C and 37 °C up to 24 h for use as oral vaccine.
The stabilisers were Lactalbumin hydrolysate-Trehalose, Lactalbumin hydrolysate-Trehalose-Gelatin, Lactalbumin hydrolysate-Lactose-Sucrose and Lactalbumin hydrolysate-Sucrose. The liquid vaccines, with or without stabilisers, were stable at 4 °C up to 24 h, whereas, a drop of one log10 titre was observed at 25 °C during the same period. At 37 °C, the virus titre diminished by only one log10 with the Lactalbumin hydrolysate-Trehalose (LT) stabiliser up to 24 h compared to two log10 losses in virus titre with other stabilisers and virus control.
We therefore conclude that for developing a CSF oral vaccine, the vaccine virus in liquid form can be used directly during the winter, whereas for developing the oral vaccine for summer, the LT stabiliser would provide maximum stability to the virus to withstand the warm temperature while maintaining adequate therapeutic titre for inducing a protective immune response.
rHu VEGF-121 |
|||
AK8331-0002 | Akron Biotech | 2µg | Ask for price |
rHu VEGF-121 |
|||
AK8331-0010 | Akron Biotech | 10µg | Ask for price |
rHu VEGF-121 |
|||
AK8331-0100 | Akron Biotech | 100µg | Ask for price |
rHu VEGF-121 |
|||
AK8331-1000 | Akron Biotech | 1mg | Ask for price |
rHu VEGF (cGMP) |
|||
AK9063-0000 | Akron Biotech | 1mg | Ask for price |
EG VEGF |
|||
cyt-338 | ProSpec Tany | 5µg | EUR 60 |
Description: Recombinant Human Endocrine Gland Vascular Endothelial Growth Factor |
EG VEGF protein |
|||
30R-AE013 | Fitzgerald | 20 ug | EUR 358 |
Description: Purified recombinant Human EG VEGF protein |
EG VEGF antibody |
|||
20R-1607 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal EG VEGF antibody |
EG VEGF antibody |
|||
70R-EG002 | Fitzgerald | 50 ug | EUR 312 |
Description: Affinity purified Goat polyclonal EG VEGF antibody |
EG VEGF Rabbit mAb |
|||
E2R389402 | EnoGene | 100ul | EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
OPPA00601-5UG - EG VEGF Protein |
|||
OPPA00601-5UG | Aviva Systems Biology | 5ug | EUR 70 |
Recombinant Human VEGF165 (rHu VEGF165) |
|||
70505 | SAB | 10ul | EUR 235 |
Description: Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human umbilical vein endothelial cells(HUVEC) is between 1.0-8.0 ng/ml. |
EG-VEGF |
|||
PR29003 | Neuromics | 5 ug | EUR 277.2 |
Recombinant Mouse EG VEGF Protein, Untagged, E.coli-1mg |
|||
QP11757-1mg | EnQuireBio | 1mg | EUR 3308.4 |
Recombinant Mouse EG VEGF Protein, Untagged, E.coli-5ug |
|||
QP11757-5ug | EnQuireBio | 5ug | EUR 186 |
Recombinant Mouse EG VEGF Protein, Untagged, E.coli-20ug |
|||
QP11757-20ug | EnQuireBio | 20ug | EUR 241.2 |
EG-VEGF Antibody |
|||
3489-100 | Biovision | each | EUR 405.6 |
EG-VEGF Antibody |
|||
3489R-100 | Biovision | each | EUR 379.2 |
EG-VEGF Antibody |
|||
3489R-30T | Biovision | each | EUR 175.2 |
Rat Endocrine gland vascular endothelial growth factor, EG- VEGF |
|||
ELA-E0024r | Lifescience Market | 96 Tests | EUR 1063.2 |
EG-VEGF Recombinant Protein |
|||
40-629 | ProSci | 5 ug | EUR 311.1 |
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal gland, and placenta. EG-VEGF induces proliferation, migration, and fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. The human EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids. Recombinant Human EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues, including ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds. |
EG-VEGF Recombinant Protein |
|||
40-702 | ProSci | 5 ug | EUR 311.1 |
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal gland, and placenta. EG-VEGF induces proliferation, migration, and fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. The murine EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids. Recombinant Murine EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues, including ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds. |
EG-VEGF, human recombinant |
|||
4571-10 | Biovision | each | EUR 183.6 |
EG-VEGF, human recombinant |
|||
4571-1000 | Biovision | each | EUR 3583.2 |
EG-VEGF, human recombinant |
|||
4571-50 | Biovision | each | EUR 483.6 |
Polyclonal EG-VEGF Antibody |
|||
APR00114G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EG-VEGF . This antibody is tested and proven to work in the following applications: |
Polyclonal EG-VEGF Antibody |
|||
APG00002G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human EG-VEGF . This antibody is tested and proven to work in the following applications: |
EG-VEGF Blocking Peptide |
|||
20-abx064278 | Abbexa |
|
|
Recombinant Human EG-VEGF |
|||
HEGFP-0503 | Cyagen | 5ug | Ask for price |
Anti-EG-VEGF Antibody |
|||
HA500078 | HUABIO | 100ul | EUR 189 |
Description: The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner. |
Recombinant Murine EG-VEGF |
|||
MEGFP-0502 | Cyagen | 5ug | Ask for price |
VEGF-A(VEGF/1063) Antibody |
|||
BNCAP1063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNCAP1063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNCH1063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNCH1063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC701063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC701063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC811063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC811063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC801063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF680 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC801063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF680 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC551063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF555 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC551063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF555 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC431063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF543 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC431063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF543 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC611063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC611063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC051063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC051063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNCA1063-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against VEGF-A(VEGF/1063), APC conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNCP1063-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against VEGF-A(VEGF/1063), PerCP conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNCR1063-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against VEGF-A(VEGF/1063), RPE conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063), 1mg/mL |
|||
BNUM1063-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), 0.2mg/mL |
|||
BNUB1063-100 | Biotium | 100uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), 0.2mg/mL |
|||
BNUB1063-500 | Biotium | 500uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF/ Rat VEGF ELISA Kit |
|||
ELA-E0143r | Lifescience Market | 96 Tests | EUR 1063.2 |
Anti-Human EG-VEGF Antibody |
|||
102-P113G | ReliaTech | 100 µg | EUR 245.7 |
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF), also called prokineticin 1 (PK1), is a member of the prokineticin family of secreted proteins that share a common structural motif containing ten conserved cysteine residues that form five pairs of disulfide bonds. Members of this family include the mammalian EG-VEGF/ PK1 and PK2, as well as the venom protein A (VPRA) from the venom of black mamba snake and the frog Bombina variegata, Bv8. Human EG-VEGF precursor is a 105 amino acid (aa) residue protein with a 19 aa signal peptide that is cleaved to yield a 86 aa mature protein. EG-VEGF is expressed in multiple tissues including the gastrointestinal (GI) tract and steroidogenic glands (testis, ovary, placenta and adrenal glands). EG-VEGF has been shown to potently stimulate the contraction of GI smooth muscle. In addition, EG-VEGF is a tissue-specific angiogenic factor that exhibits biological activities similar to that of VEGF on select cells. It induces the proliferation, migration, and fenestration in cultured endocrine gland-derived capillary endothelial cells. EG-VEGF binds to and activates two closely related G proteincoupled receptors, EG-VEGF/ PK1R1 and EG-VEGF/ PK2R2. Activation of the receptors leads to stimulation of phosphoinositide turnover and activation of p44/p42 MAP kinase signaling pathways. |
Anti-Human EG-VEGF Antibody |
|||
101-M158 | ReliaTech | 100 µg | EUR 399 |
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF), also called prokineticin 1 (PK1), is a member of the prokineticin family of secreted proteins that share a common structural motif containing ten conserved cysteine residues that form five pairs of disulfide bonds. Members of this family include the mammalian EG-VEGF/ PK1 and PK2, as well as the venom protein A (VPRA) from the venom of black mamba snake and the frog Bombina variegata, Bv8. Human EG-VEGF precursor is a 105 amino acid (aa) residue protein with a 19 aa signal peptide that is cleaved to yield a 86 aa mature protein. EG-VEGF is expressed in multiple tissues including the gastrointestinal (GI) tract and steroidogenic glands (testis, ovary, placenta and adrenal glands). EG-VEGF has been shown to potently stimulate the contraction of GI smooth muscle. In addition, EG-VEGF is a tissue-specific angiogenic factor that exhibits biological activities similar to that of VEGF on select cells. It induces the proliferation, migration, and fenestration in cultured endocrine gland-derived capillary endothelial cells. EG-VEGF binds to and activates two closely related G proteincoupled receptors, EG-VEGF/ PK1R1 and EG-VEGF/ PK2R2. Activation of the receptors leads to stimulation of phosphoinositide turnover and activation of p44/p42 MAP kinase signaling pathways. |
Anti-Human EG-VEGF Antibody |
|||
101-M633 | ReliaTech | 100 µg | EUR 399 |
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF), also called prokineticin 1 (PK1), is a member of the prokineticin family of secreted proteins that share a common structural motif containing ten conserved cysteine residues that form five pairs of disulfide bonds. Members of this family include the mammalian EG-VEGF/ PK1 and PK2, as well as the venom protein A (VPRA) from the venom of black mamba snake and the frog Bombina variegata, Bv8. Human EG-VEGF precursor is a 105 amino acid (aa) residue protein with a 19 aa signal peptide that is cleaved to yield a 86 aa mature protein. EG-VEGF is expressed in multiple tissues including the gastrointestinal (GI) tract and steroidogenic glands (testis, ovary, placenta and adrenal glands). EG-VEGF has been shown to potently stimulate the contraction of GI smooth muscle. In addition, EG-VEGF is a tissue-specific angiogenic factor that exhibits biological activities similar to that of VEGF on select cells. It induces the proliferation, migration, and fenestration in cultured endocrine gland-derived capillary endothelial cells. EG-VEGF binds to and activates two closely related G proteincoupled receptors, EG-VEGF/ PK1R1 and EG-VEGF/ PK2R2. Activation of the receptors leads to stimulation of phosphoinositide turnover and activation of p44/p42 MAP kinase signaling pathways. |
Human EG-VEGF Recombinant Protein |
|||
100-150 | ReliaTech | 20 µg | EUR 196.35 |
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) induces proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands. Its expression is induced by hypoxia and is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta). Its expression is often complementary to the expression of VEGF (MIM 192240), suggesting that these molecules function in a coordinated manner. EG-VEGF potently contracts gastrointestinal (gi) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types. |
Human EG-VEGF Recombinant Protein |
|||
100-150S | ReliaTech | 5 µg | EUR 92.4 |
Description: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) induces proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands. Its expression is induced by hypoxia and is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta). Its expression is often complementary to the expression of VEGF (MIM 192240), suggesting that these molecules function in a coordinated manner. EG-VEGF potently contracts gastrointestinal (gi) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types. |
Rabbit anti-EG-VEGF Antibody |
|||
DL92084A-100ul | DL Develop | 100 ul | EUR 299 |
Description: Prokineticin-1; Endocrine-gland-derived vascular endothelial growth factor; EG-VEGF; Mambakine |
Rabbit anti-EG-VEGF Antibody |
|||
DL92084A-50ul | DL Develop | 50 ul | EUR 209.3 |
Description: Prokineticin-1; Endocrine-gland-derived vascular endothelial growth factor; EG-VEGF; Mambakine |
Porcine EG-VEGF ELISA Kit |
|||
EPE0137 | Abclonal | 96Tests | EUR 625.2 |
Rat EG-VEGF ELISA Kit |
|||
ERE0137 | Abclonal | 96Tests | EUR 625.2 |
Mouse EG-VEGF ELISA Kit |
|||
EME0137 | Abclonal | 96Tests | EUR 625.2 |
Monkey EG-VEGF ELISA Kit |
|||
EMKE0137 | Abclonal | 96Tests | EUR 625.2 |
Rabbit EG-VEGF ELISA Kit |
|||
ERTE0137 | Abclonal | 96Tests | EUR 625.2 |
Sheep EG-VEGF ELISA Kit |
|||
ESE0137 | Abclonal | 96Tests | EUR 625.2 |
EG-VEGF (Human) ELISA Kit |
|||
EKA51829-5x96T | Biomatik Corporation | 5x96T | Ask for price |
EG-VEGF (Human) ELISA Kit |
|||
EKA51829-96T | Biomatik Corporation | 96T | EUR 446.9 |
Human EG-VEGF ELISA Kit |
|||
EK5247 | SAB | 96 tests | EUR 599 |
Goat EG-VEGF ELISA Kit |
|||
EGTE0137 | Abclonal | 96Tests | EUR 625.2 |
Anserini EG-VEGF ELISA Kit |
|||
EAE0137 | Abclonal | 96Tests | EUR 625.2 |
Chicken EG-VEGF ELISA Kit |
|||
ECKE0137 | Abclonal | 96Tests | EUR 625.2 |
EG-VEGF ELISA KIT|Human |
|||
EF000094 | Lifescience Market | 96 Tests | EUR 826.8 |
Canine EG-VEGF ELISA Kit |
|||
ECE0137 | Abclonal | 96Tests | EUR 625.2 |
Bovine EG-VEGF ELISA Kit |
|||
EBE0137 | Abclonal | 96Tests | EUR 625.2 |
Human EG-VEGF ELISA Kit |
|||
EHE0137 | Abclonal | 96Tests | EUR 625.2 |
Prokineticin 1 (EG-VEGF) Antibody |
|||
20-abx007755 | Abbexa |
|
|
Mouse EG-VEGF Recombinant Protein |
|||
M10-236 | ReliaTech | 20 µg | EUR 196.35 |
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal and placenta. EG-VEGF induces proliferation and migration fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. The murine EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids. Recombinant murine EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues and ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds. |
Mouse EG-VEGF Recombinant Protein |
|||
M10-236S | ReliaTech | 5 µg | EUR 92.4 |
Description: EG-VEGF is a secreted angiogenetic mitogen growth factor expressed in the steroidogenic glands, ovary, testis, adrenal and placenta. EG-VEGF induces proliferation and migration fenestration (formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. The murine EG-VEGF gene codes for a 105 amino acid polypeptide containing an N-terminal signal sequence of 19 amino acids. Recombinant murine EG-VEGF is a 9.6 kDa protein consisting of 86 amino acid residues and ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds. |
Human EG-VEGF ELISA kit |
|||
LF-EK50695 | Abfrontier | 1×96T | EUR 777.6 |
Human EG-VEGF ELISA Kit |
|||
GWB-SKR013 | GenWay Biotech | 96 Tests | Ask for price |
Human EG-VEGF ELISA Kit |
|||
GWB-ZZD183 | GenWay Biotech | 1x96 well plate | Ask for price |
EG-VEGF Antibody / Prokineticin 1 |
|||
R32153 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Prokineticin-1 is also known as EG-VEGF. The International Radiation Hybrid Mapping Consortium mapped the PROK1 gene to chromosome 1. The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner. |
Eg-Vegf Antibody / Prokineticin-1 |
|||
R32231 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Prokineticin-1 is also known as EG-VEGF. The International Radiation Hybrid Mapping Consortium mapped the PROK1 gene to chromosome 1. The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner. |
Human EG-VEGF GENLISA ELISA |
|||
KB1036 | Krishgen | 1 x 96 wells | EUR 198 |
OPSD00006-5UG - Recombinant EG-VEGF |
|||
OPSD00006-5UG | Aviva Systems Biology | 5ug | EUR 108 |
Rabbit anti-EG-VEGF Antibody |
|||
YLD2727-100ul | Shanghai YL Biotech | 100 ul | EUR 320 |
Description: Rabbit polyclonal antibody to EG-VEGF |
Rabbit anti-EG-VEGF Antibody |
|||
YLD2727-50ul | Shanghai YL Biotech | 50 ul | EUR 200 |
Description: Rabbit polyclonal antibody to EG-VEGF |
Recombinant Human EG-VEGF (PROK1) |
|||
Z100145 | ABM | 20 µg | EUR 235 |
Description: This factor is identical to prokineticin-1 and is a member of the AVIT protein family. Expression of human EG-VEGF messenger RNA is restricted to the steroidogenic glands, ovary, testis, adrenal and placenta and is often complementary to the expression of VEGF. EG-VEGF has been identified as a mitogen specific for the endothelium of steroidogenic glands. EG-VEGF resembles VEGF in that it causes extensive angiogenesis and cyst formation when delivered in the ovary. EG-VEGF differs from VEGF in that it does not promote angiogenesis in the cornea or skeletal muscle. Two receptors have been characterized and are expressed in gastrointestinal organs, endocrine glands and other tissues. The G-protein-coupled receptors ZAQ and I5E both function as the EG-VEGF receptor. |
Recombinant Human EG-VEGF (PROK1) |
|||
Z100149 | ABM | 1.0 mg | EUR 3900 |
Description: This factor is identical to prokineticin-1 and is a member of the AVIT protein family. Expression of human EG-VEGF messenger RNA is restricted to the steroidogenic glands, ovary, testis, adrenal and placenta and is often complementary to the expression of VEGF. EG-VEGF has been identified as a mitogen specific for the endothelium of steroidogenic glands. EG-VEGF resembles VEGF in that it causes extensive angiogenesis and cyst formation when delivered in the ovary. EG-VEGF differs from VEGF in that it does not promote angiogenesis in the cornea or skeletal muscle. Two receptors have been characterized and are expressed in gastrointestinal organs, endocrine glands and other tissues. The G-protein-coupled receptors ZAQ and I5E both function as the EG-VEGF receptor. |
VEGF |
|||
E8ET1604-28 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
VEGF |
|||
GWB-400310 | GenWay Biotech | 0.01 mg | Ask for price |
VEGF |
|||
cyt-241 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor |
VEGF |
|||
ant-125 | ProSpec Tany | 0.5mg | EUR 275 |
Description: Mouse Anti Human Vascular Endothelial Growth Factor |
VEGF |
|||
LF-PR009 | Abfrontier | 10 ug | EUR 306 |
Description: VEGF protein |
VEGF |
|||
MO15067 | Neuromics | 500 ug | EUR 1092 |
VEGF |
|||
PR15028 | Neuromics | 10 ug | EUR 553.2 |
VEGF Rabbit Polyclonal Antibody(VEGF) |
|||
RA20266-100ul | Reed Biotech | 100 ul | EUR 298 |
VEGF Rabbit Polyclonal Antibody(VEGF) |
|||
RA20266-50ul | Reed Biotech | 50 ul | EUR 198 |
VEGF 121 |
|||
PR15029 | Neuromics | 5 ug | EUR 498 |
VEGF 162 |
|||
PR15030 | Neuromics | 25 ug | EUR 553.2 |
VEGF 165 |
|||
PR15031 | Neuromics | 50 ug | EUR 1477.2 |
VEGF 120 |
|||
PR15033 | Neuromics | 5 ug | EUR 459.6 |
VEGF 164 |
|||
PR15034 | Neuromics | 25 ug | EUR 1352.4 |
VEGF 164 |
|||
PR15035 | Neuromics | 50 ug | EUR 1477.2 |
VEGF (121a.a.) |
|||
cyt-343 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor (121) |
VEGF-A/ Rat VEGF- A ELISA Kit |
|||
ELA-E1851r | Lifescience Market | 96 Tests | EUR 1063.2 |
VEGF-B/ Rat VEGF- B ELISA Kit |
|||
ELA-E0144r | Lifescience Market | 96 Tests | EUR 1063.2 |
VEGF-C/ Rat VEGF- C ELISA Kit |
|||
ELA-E0145r | Lifescience Market | 96 Tests | EUR 1063.2 |
VEGF-D/ Rat VEGF- D ELISA Kit |
|||
ELA-E0146r | Lifescience Market | 96 Tests | EUR 1063.2 |
VEGF-A(VEGF/1063), CF568 conjugate, 0.1mg/mL |
|||
BNC681063-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF568 conjugate, 0.1mg/mL |
|||
BNC681063-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF647 conjugate, 0.1mg/mL |
|||
BNC471063-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF647 conjugate, 0.1mg/mL |
|||
BNC471063-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF594 conjugate, 0.1mg/mL |
|||
BNC941063-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF594 conjugate, 0.1mg/mL |
|||
BNC941063-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), Biotin conjugate, 0.1mg/mL |
|||
BNCB1063-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), Biotin conjugate, 0.1mg/mL |
|||
BNCB1063-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF488A conjugate, 0.1mg/mL |
|||
BNC881063-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF488A conjugate, 0.1mg/mL |
|||
BNC881063-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF405S conjugate, 0.1mg/mL |
|||
BNC041063-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF405S conjugate, 0.1mg/mL |
|||
BNC041063-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF640R conjugate, 0.1mg/mL |
|||
BNC401063-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), CF640R conjugate, 0.1mg/mL |
|||
BNC401063-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF D |
|||
cyt-045 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor D |
VEGF, CF |
|||
PR15028CF | Neuromics | 10 ug | EUR 553.2 |
VEGF, HEK |
|||
cyt-225 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor, HEK |
VEGF, CHO |
|||
cyt-260 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor, CHO |
VEGF, His |
|||
cyt-496 | ProSpec Tany | 5µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor, His Tag |
mEG VEGF |
|||
cyt-825 | ProSpec Tany | 5µg | EUR 60 |
Description: Recombinant Mouse Endocrine Gland Vascular Endothelial Growth Factor |
VEGF rat |
|||
JP27101 | Demeditec Diagnostics | 96 | EUR 611 |
VEGF-C |
|||
JP27756 | Demeditec Diagnostics | 96 | EUR 611 |
VEGF-B |
|||
RA26004 | Neuromics | 100 ul | EUR 646.8 |
VEGF-D |
|||
RA26005 | Neuromics | 100 ul | EUR 646.8 |
VEGF-C |
|||
PR27170 | Neuromics | 2 ug | EUR 229.2 |
VEGF-C |
|||
PR27170-B | Neuromics | each | EUR 2519.1 |
VEGF-C |
|||
PR27170-M | Neuromics | each | EUR 175.5 |
VEGF 121, CF |
|||
PR15029CF | Neuromics | 5 ug | EUR 498 |
VEGF 162, CF |
|||
PR15030CF | Neuromics | 25 ug | EUR 553.2 |
VEGF 165, CF |
|||
PR15031CF | Neuromics | 50 ug | EUR 1477.2 |
VEGF 164, CF |
|||
PR15034CF | Neuromics | 5 ug | EUR 459.6 |
VEGF 164, CF |
|||
PR15035CF | Neuromics | 50 ug | EUR 1477.2 |
Goat(VEGF) |
|||
QY-E140039 | Qayee Biotechnology | 96T | EUR 495.6 |
Guinea Pig EG-VEGF ELISA Kit |
|||
EGE0137 | Abclonal | 96Tests | EUR 625.2 |
Human EG-VEGF PicoKine ELISA Kit |
|||
EK0575 | BosterBio | 96 wells | EUR 547.2 |
Description: For quantitative detection of human EG-VEGF in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human EG-VEGF ELISA kit (4X96T) |
|||
LF-EK50696 | Abfrontier | 4×96T | EUR 2641.2 |
Mouse EG-VEGF Recombinant Protein Lyophilized |
|||
IMSEGVEGFRLY5UG | Innovative research | each | EUR 317 |
Description: Mouse EG-VEGF Recombinant Protein Lyophilized |
Human EG-VEGF Recombinant Protein Lyophilized |
|||
IHUEGVEGFRLY5UG | Innovative research | each | EUR 317 |
Description: Human EG-VEGF Recombinant Protein Lyophilized |
EG-VEGF ELISA Kit (Human) (OKBB00283) |
|||
OKBB00283 | Aviva Systems Biology | 96 Tests | EUR 652.8 |
Description: Description of target: EG-VEGF, Endocrine glandderived vascular endothelial growth factor, is a human protein encoded by by the PROKR1 gene. Its gene is mapped to chromosome 1. The 1.4-kb cDNA encodes a protein of 105 amino acids with a well defined signal sequence. The mature protein is predicted to have 86 amino acids. Northern blot analysis demonstrated expression in testis, ovary, adrenal gland, and placenta. EG-VEGF has played a vital role in inducing proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 7 pg/mL |
VEGF-121-Fc |
|||
E13-m005-1 | EnoGene | 10μg | EUR 225 |
Description: N/A |
VEGF-121-Fc |
|||
E13-m005-2 | EnoGene | 50μg | EUR 1125 |
Description: N/A |
VEGF-165-Fc |
|||
E13-m006-1 | EnoGene | 10μg | EUR 225 |
Description: N/A |
VEGF-165-Fc |
|||
E13-m006-2 | EnoGene | 50μg | EUR 1125 |
Description: N/A |
VEGF, Plant |
|||
cyt-1213 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor, Plant |
VEGF, Yeast |
|||
cyt-577 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor, Yeast |
VEGF mouse |
|||
JP27102 | Demeditec Diagnostics | 96 | EUR 611 |
VEGF human |
|||
JP27171 | Demeditec Diagnostics | 96 | EUR 611 |
VEGF (121a.a.), HEK |
|||
cyt-116 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor (121), HEK |
VEGF (121a.a.), Sf9 |
|||
cyt-200 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor (121), Sf9 |
VEGF (121a.a.), His |
|||
cyt-619 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Vascular Endothelial Growth Factor (121), His Tag |
rHu MIF |
|||
AK8255-0005 | Akron Biotech | 5µg | Ask for price |
rHu MIF |
|||
AK8255-0025 | Akron Biotech | 25µg | Ask for price |
rHu MIF |
|||
AK8255-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIF |
|||
AK8255-1000 | Akron Biotech | 1mg | Ask for price |
rHu EGF |
|||
AK8327-0100 | Akron Biotech | 100µg | Ask for price |
rHu EGF |
|||
AK8327-0500 | Akron Biotech | 500µg | Ask for price |